A pill for all by the year 2000?

Preventive Medicine

Volumn 28, Issue 6, 1999, Pages 600-607

  Barrett Connor, Elizabeth ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hormones; Pills; Prevention; Public health; Screening; Vitamins

Indexed keywords

ALPHA TOCOPHEROL; AMOXICILLIN; ANOREXIGENIC AGENT; ASCORBIC ACID; BETA CAROTENE; CAFFEINE; CHLORDIAZEPOXIDE; ESTROGEN; FLUOXETINE; LYCOPENE; METHYLPHENIDATE; NON PRESCRIPTION DRUG; PLACEBO; PRASTERONE SULFATE; PROBUCOL; SILDENAFIL; TESTOSTERONE; VITAMIN;

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COUNSELING; DIET SUPPLEMENTATION; DRUG INDUSTRY; ESTROGEN DEFICIENCY; EXERCISE; HEALTH PROMOTION; HIGH RISK POPULATION; HUMAN; NUTRIENT; PILL; PRESCRIPTION; PRIMARY PREVENTION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RISK BENEFIT ANALYSIS; UNITED STATES; WEIGHT REDUCTION;

EID: 0032773433     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1006/pmed.1999.0488     Document Type: Article

References (32)

1. U.S. Public Health Service. Fortune 1941;21:81-110.
2. Lancet. 351:1998;921.
3. Tanouye E. The fine print. The Wall Street Journal. 1998;R67.
4. Ann Epidemiol. 4:1994;1-10.
5. Edelman E R. Vessel size, antioxidants, and restenosis. Never too small, not too little, but often too late. Circulation. 97:1998;416-420.
6. Omenn G S, Beresford SA A, Motulsky A G. Preventing coronary heart disease. B vitamins and homocysteine. Circulation. 97:1998;421-424.
7. Oakley G P. Jr. Eat right and take a multivitamin [editorial]. N Engl J Med. 338:1998;1060-1061.
8. Appel L J, Moore T J, Obarzanek E, Vollmer W M, Svetkey L P, Sacks F M. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 336:1997;1117-1124.
9. Grady D, Rubin S M, Petitti D B. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 117:1992;1016-1037.
10. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in post-menopausal women. JAMA. 280:1998;605-613.
11. Beral V, Bull D, Doll R, Key T, Peto R, Reeves G. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet. 350:1997;1047-1059.
12. Barret-Connor E, Wenger N K, Grady D, Mosca L, Collins P, Kornitzer M, Cox D A, Moscarelli E, Anderson P W. Hormone and nonhormone therapy for the maintenance of postmenopausal health: the need for randomized controlled trials of estrogen and raloxifene. J Women Health. 7:1998;839-847.
13. Ferrini R L, Barrett-Connor E. Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am J Epidemiol. 147:1998;750-754.
14. Rothman D J. The problem with "cosmetic psychopharmacology." Shiny happy people. The New Republic. 1994;34-38.
15. Rose, G, A. The strategy of preventive medicine. New York, Oxford Univ. Press, 1992.
16. Braunwald E. Shattuck lecture - cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med. 337:1997;1360-1369.
17. Frank E. Osler was wrong: you are a preventionist. Am J Prev Med. 7:1991;128.
18. Barry D. Call me in the morning. International Herald Tribune. 1998;2.
19. Fraser M. Availability and reimbursement of bone mineral density measurement in European countries: a European foundation for osteoporosis report. Osteoporosis Int. 7:1997;496-499.
20. Whelton P K, Kumanyika S K, Cook N R, Cutler J A, Borhani N O, Hennekens C H. Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure results from phase 1 of the Trials of Hypertension Prevention. Am J Clin Nutr. 1997;652S-60S.
21. Poulter, N, Sever, P, Thom, S. Cardiovascular disease. Practical issues for prevention. 2nd ed. Surrey(UK): Lynn Whitfield, 1996.
22. MWWR. 47:1998;91-95.
23. Hill M N. Behavior and biology: the basic sciences for AHA action. Circulation. 97:1998;807-810.
24. Healthy People 2000: national health promotion and disease prevention objectives. 1991;U.S. Department Health and Human Services.
25. Guide to clinical preventive service. Promoting physical activity. 1996;U.S. Preventive Services Task Force.
26. Stefanick M L, Macky S, Sheehan M, Ellsworth N, Haskell W L, Wood P D. Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol. N Engl J Med. 339:1998;12-20.
27. Long B J, Calfas K J, Wooten W, Sallis J F, Patrick K, Goldstein M. A multisite field test of the acceptability of physical activity counseling in primary care: project PACE. Am J Prev Med. 12:1996;73-81.
28. Calfas K J, Long B J, Sallis J F, Wooten W J, Pratt M, Patrick K. A controlled trial of physician counseling to promote the adoption of physical activity. Prev Med. 25:1996;225-233.
29. Maliszewski A F, Freedson P S, Ebbelling C J, Crussemeyer J, Kastango K B. Validity of the Caltrac accelerometer in estimating energy expenditure and activity in children and adults. Pediatr Exerc Sci. 3:1991;141-151.
30. Parens E. Is good always better? The Enhancement Project. Hasting Center Report. 28:1988;S1-17.
31. Coy, P. Is this prescription necessary?, Business Week 1998 May 11; p, 98.
32. Vandenbroucke J P. Postmenopausal oestrogen and cardioprotection. Lancet. 337:1991;833-834.